Study of MK-1697 in Participants With Advanced Solid Tumors (MK-1697-001)

Clinical trial NCT03515824 · TERMINATED

Trial details

NCT number: NCT03515824
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Neoplasms Colorectal Neoplasms Head and Neck Neoplasms

Start date: 2018-08-13
Primary completion: 2020-02-18
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.